VEGFA and retinopathy of prematurity: In this study, the nontype 1 ROP cases who had received intravitreal injection of anti-VEGF drugs in our hospital were enrolled to analyze the treatment effect, clinical characteristics, and treatment reasons and to explore the personalized diagnosis and treatment for ROP with special clinical characteristics.